Home › Trial NCT05154630
Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
- Trial IDNCT05154630
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrollment8
- Start date2022-01-14
- ConditionsAdvanced Cancer · Advanced Soft-tissue Sarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.